Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Craig Landau as its CEO

He also takes up president role

Craig Landau Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the firm’s US operations and retain responsibility for Purdue’s Canadian operations.

Landau first joined the Connecticut, US-based firm as president and CEO of Purdue Pharma Canada, he's spent the last three years diversifying and stabilising the business through a number of strategic business development deals.

He said: "I am honoured to be leading these organisations at such an exciting time.

"I look forward to building on Purdue’s rich history and working with my talented colleagues as we continue to broaden our portfolio and innovate to support healthcare professionals and serve patient needs.”

He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.

29th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics